HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clean Label Contaminant Study, NSF DNA Authenticated: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Trade groups criticize Clean Label study; NSF testing protocol for raw botanicals; Dorothy Hamill works with Nature's Bounty as health and wellness advocate; Optimum Nutrition launches 100% Plant, s first plant-based Gold Standard whey protein powder; and more news in brief.

You may also be interested in...



Retailers’ Advances In Tracking Customer Data Push Larger Class Action Settlements

Class action litigants gain larger settlements by subpoenaing retailers’ loyalty program data and customer analytics. 

Tests Finding Smaller Contaminants Making Big Impact In Class Action Complaints

Lab tests can identify contaminants in supplements down to the parts-per-billion or even -trillion, increasing the number of class action suits alleging false “pure” and “free of” claims.

Else Nutrition Takes 'Clean Label' Into Infant Formula, Toddler Beverage Market

Else Nutrition will be one of the first companies to market baby and toddler formula and a children’s beverage without dairy or soy while containing a few core ingredients, says CEO Hamutal Yitzhak. Products will debut in North America and Europe in 2020.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel